# Hepatotoxicity of Antituberculosis Therapy (HAT) Study

> **NCT04159441** · — · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 5000 (estimated)

## Conditions studied

- Chemical and Drug Induced Liver Injury

## Interventions

- **OTHER:** None intervetion

## Key facts

- **NCT ID:** NCT04159441
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-05
- **Primary completion:** 2020-12-05
- **Final completion:** 2021-06-05
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159441, "Hepatotoxicity of Antituberculosis Therapy (HAT) Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04159441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*